Volume 85, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



All the records from the Spanish information system for hospital data of patients diagnosed with leishmaniasis during a 12-year period (1997–2008) were studied. The 2,028 individuals were hospitalized because of leishmaniasis, as indicated by the principal diagnostic code. The average hospitalization rate was 0.41/100,000 inhabitants. One-third of them were co-infected with human immunodeficiency virus (HIV). The incidence of hospitalization in the adult population with leishmaniasis co-infected with HIV increased with age, peaked at 35–39 years of age and subsequently declined. In the pediatric population, all leishmaniasis cases occurred in HIV-negative children. Incidence of hospitalizations was highest in Madrid and in the Mediterranean coast. The cost per inpatient hospital care was $9,601 corresponding to an annual direct cost of more than $1.5 million for inpatient care alone. The economical burden of leishmaniasis is not neglectable and in the 12-year study period it represented more than $19 million.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. WHO, 2010. Leishmaniasis. Available at: http://www.who.int/topics/leishmaniasis/en/. Accessed July 25, 2010. [Google Scholar]
  2. Alvar J, , 2001. Leishmaniasis: from boilogy to control. Second edition. Salamanca: Laboratorios Intervet S.A. [Google Scholar]
  3. Desjeux P, Alvar J, , 2003. Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol 97 (Suppl 1): 315.[Crossref] [Google Scholar]
  4. Alvar J, Aparicio P, Aseffa A, Den Boer M, Cañavate C, Dedet JP, Gradoni L, Ter Horst R, López-Vélez R, Moreno J, , 2008. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21: 334359.[Crossref] [Google Scholar]
  5. Tortajada C, Pérez-Cuevas B, Moreno A, Martínez E, Mallolas J, García F, Valls E, Miró JM, De Lazzari E, Gatell JM, , 2002. Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients. J Acquir Immune Defic Syndr 30: 364366.[Crossref] [Google Scholar]
  6. López-Vélez R, Casado JL, Pintado V, , 2001. Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART). Clin Microbiol Infect 7: 394395.[Crossref] [Google Scholar]
  7. Mira JA, Corzo JE, Rivero A, Macias J, De Leon FL, Torre-Cisneros J, Gomez-Mateos J, Jurado R, Pineda JA, , 2004. Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. Am J Trop Med Hyg 70: 298301. [Google Scholar]
  8. World Health Assembly, 2007. Control of leishmaniasis. 60th World Health Assembly, 9th plenary meeting, 21 May 2007. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA60/A60_R13-en.pdf. Accessed April 11, 2011. [Google Scholar]
  9. Bern C, Maguire JH, Alvar J, , 2008. Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis 2: e313.[Crossref] [Google Scholar]
  10. Ministerio de Sanidad y Consumo, 2010. International Classification of Diseases 9th revision Clinical Modification. Available at: http://www.msc.es/estadEstudios/estadisticas/normalizacion/clasifEnferm/instrucNorma.htm. Accessed March 22, 2011. [Google Scholar]
  11. National Health Insurance, 2002. Deputy Directors Office of Administrative Coordination. National Information System for Hospital Data (CMBD) INSALUD hospitals 2001. Madrid, Spain. Available at: www.ingesa.msc.es/. Accessed March 22, 2011. [Google Scholar]
  12. Rivero Cuadrado A., , 2000. The minimum data set in the NHS: early and ongoing developments. Rev Fuentes Estadísticas 49:1819. Available at: http://www.webcitation.org/query.php?url=http://www.fuentesestadisticas.com/Numero49/Paginas/18-19.htm&refdoi=10.1186/1471-2458-8-109. Accessed January 20, 2010. [Google Scholar]
  13. Gil Prieto R, San Román Montero J, Gómez Alejandre C, Alvaro Meca LA, Rivero A, Gil de Miguel A, , 2009. Epidemiology of pneumococcal meningitis hospitalizations in pediatric population in Spain (1998–2006). Vaccine 27: 26692673.[Crossref] [Google Scholar]
  14. Schreyögg J, Stargardt T, Tiemann O, Busse R, , 2006. Methods to determine reimbursement rates for diagnosis related groups (DRG): a comparison of nine European countries. Health Care Manage Sci 9: 215223.[Crossref] [Google Scholar]
  15. Valcárcel Y, Bastero R, Anegón M, González S, Gil A, , 2008. The epidemiology of hospital admissions due to leishmaniasis in Spain (1999–2003). Enferm Infecc Microbiol Clin 26: 278281.[Crossref] [Google Scholar]
  16. Alvar J, Cañavate C, Gutiérrez-Solar B, Jiménez M, Laguna F, López-Vélez R, Molina R, Moreno J, , 1997. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 10: 298319. [Google Scholar]
  17. CMBD, 2010. CMBD date. Available at: http://www.msc.es/en/estadEstudios/estadisticas/cmbdhome.htm. Accessed May 30, 2010. [Google Scholar]
  18. Kubar J, Marty P, Lelièvre A, Quaranta JF, Staccini P, Caroli-Bosc C, Le Fichoux Y, , 1998. Visceral leishmaniasis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts. AIDS 12: 21472153.[Crossref] [Google Scholar]
  19. Cruz I, Morales MA, Noguer I, Rodríguez A, Alvar J, , 2002. Leishmania in discarded syringes from intravenous drug users. Lancet 359: 11241125.[Crossref] [Google Scholar]
  20. Bettini S, Gramiccia M, Gradoni L, Pozio E, Mugnai S, Maroli M, , 1983. Leishmaniasis in Tuscany (Italy). VIII. Human population response to leishmanin in the focus of Monte Argentario (Grosseto) and epidemiological evaluation. Ann Parasitol Hum Comp 58: 539547. [Google Scholar]
  21. Marty P, Le Fichoux Y, Giordana D, Brugnetti A, , 1992. Leishmanin reaction in the human population of a highly endemic focus of canine leishmaniasis in Alpes-Maritimes, France. Trans R Soc Trop Med Hyg 86: 249259.[Crossref] [Google Scholar]
  22. Acedo Sánchez C, Martín Sánchez J, Vélez Bernal ID, Sanchís Marín MC, Louassini M, Maldonado JA, Morillas Márquez F, , 1996. Leishmaniasis eco-epidemiology in the Alpujarra region (Granada Province, southern Spain). Int J Parasitol 26: 303310.[Crossref] [Google Scholar]
  23. Alvar J, Cañavate C, Molina R, Moreno J, Nieto J, , 2004. Canine leishmaniasis. Adv Parasitol 57: 188.[Crossref] [Google Scholar]
  24. Dedet JP, Pillot B, Gentilini M, , 1991. Evaluation of the socioeconomic costs of cutaneous leishmaniasis in French Guiana. Rev Epidemiol Sante Publique 39: 129133. [Google Scholar]
  25. Peiro S, Librero J, , 1999. The quality assessment from the minimum basic hospital discharge data set. Rev Neurol 29: 651661. [Google Scholar]

Data & Media loading...

  • Received : 13 May 2011
  • Accepted : 01 Aug 2011
  • Published online : 01 Nov 2011

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error